Exchange Traded Concepts LLC Acquires 322 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Exchange Traded Concepts LLC lifted its holdings in USANA Health Sciences, Inc. (NYSE:USNA) by 4.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,709 shares of the company’s stock after acquiring an additional 322 shares during the period. Exchange Traded Concepts LLC’s holdings in USANA Health Sciences were worth $292,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in USNA. Pzena Investment Management LLC boosted its stake in shares of USANA Health Sciences by 24.4% in the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after acquiring an additional 191,289 shares during the period. Pacer Advisors Inc. boosted its stake in USANA Health Sciences by 14.3% during the second quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock valued at $21,143,000 after buying an additional 58,597 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in USANA Health Sciences by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 109,252 shares of the company’s stock valued at $4,943,000 after buying an additional 27,053 shares during the last quarter. Deerfield Management Company L.P. Series C boosted its stake in USANA Health Sciences by 297.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock valued at $1,346,000 after buying an additional 22,251 shares during the last quarter. Finally, WINTON GROUP Ltd bought a new position in USANA Health Sciences during the second quarter valued at approximately $890,000. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Trading Down 1.0 %

Shares of USANA Health Sciences stock opened at $35.85 on Monday. The firm has a market cap of $682.94 million, a PE ratio of 12.54, a PEG ratio of 1.20 and a beta of 0.89. USANA Health Sciences, Inc. has a 12 month low of $34.76 and a 12 month high of $57.78. The stock has a 50 day moving average of $38.15 and a 200 day moving average of $42.76.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.11). The company had revenue of $212.87 million during the quarter, compared to the consensus estimate of $218.64 million. USANA Health Sciences had a net margin of 6.29% and a return on equity of 11.13%. During the same period in the previous year, the business earned $0.89 earnings per share. As a group, equities research analysts forecast that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Paul A. Jones sold 6,266 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total value of $240,489.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, Director Gilbert A. Fuller sold 674 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total value of $26,751.06. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Paul A. Jones sold 6,266 shares of the stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $38.38, for a total value of $240,489.08. The disclosure for this sale can be found here. Insiders sold 7,940 shares of company stock valued at $311,670 in the last ninety days. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. DA Davidson dropped their price target on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, July 25th. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.